InsidersTradesSigma
SB성보 Stock: price and management transactions · South Korea · DART (FSS)
Follow the SB성보 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, SB성보 has published 47 reports. Market capitalisation: €5.1bn. The latest transaction was filed on 30 June 2026 (Other). Among the most active insiders: 윤정선. The full history is free.
47
Insider Decl.
0
Thresholds
·
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate SB성보 Buy (bullish), based on 7 analysts. Average price target: €43.32.
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 2,542 of 26,182 companies
74.0
score / 100
Value89
Quality59
FCF yld22%
Earn yld17%
EV/EBITDA7.1x
ROE18%
Gross mgn34%
Net mgn16%
Debt/EBITDA4.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 June 2026
Declarations47 total
25 of 47 declarations
About SB성보
SB성보 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market.